Health Care: Drugs

Seattle Genetics Inc (SGEN: NASDAQ)

$35.6 0.48 | 1.37%
03/05/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 286.76M 269.26M 210.81M 94.78M
Cost of Sales 16.72M 10.65M 4.74M 3.12M
Gross Operating Profit 270.04M 258.62M 206.08M 91.66M
Selling, General, and Administrative Expenses 104.32M 92.35M 84.30M 72.66M
Research & Development 230.74M 218.63M 170.30M 163.40M
Operating Income before D & A (EBITDA) -65.02M -52.36M -48.52M -144.39M
Depreciation & Amortization 12.34M 10.50M 8.73M 16.64M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 1.22M 341.00K 3.47M -7.64M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -76.14M -62.52M -53.78M -168.67M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -76.14M -62.52M -53.78M -168.67M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -76.14M -62.52M -53.78M -152.03M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -76.14M -62.52M -53.78M -152.03M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -76.14M -62.52M -53.78M -152.03M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-76.14M -62.52M -53.78M -152.03M
Preferred Dividends
Net Income Available To Common -76.14M -62.52M -53.78M -152.03M
Basic EPS from Continuing Ops. -0.62 -0.51 -0.46 -1.34
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.62 -0.51 -0.46 -1.34
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.62 -0.51 -0.46 -1.34
Basic Normalized Net Income/Share -0.62 -0.51 -0.46 -1.34
EPS fr Continuing Ops. -0.62 -0.51 -0.46 -1.34
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.62 -0.51 -0.46 -1.34
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.62 -0.51 -0.46 -1.34
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.62 -0.51 -0.46 -1.34
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SGEN

Latest SGEN Headlines from TheStreet

More Financial News for SGEN

Press Releases for SGEN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter